Multiple immune cell populations and pathways

The term Multiple immune cell populations and pathways refers to a broad therapeutic strategy rather than a single molecular target. It describes the simultaneous modulation of various components of the innate and adaptive immune systems, including T cells, B cells, natural killer cells, and myeloid lineages, as well as their associated signaling networks like the JAK-STAT or NF-kB pathways (Janeway et al., Immunobiology, 2001). This systemic approach is characteristic of traditional broad-spectrum immunomodulators and immunosuppressants, such as corticosteroids and certain antimetabolites, which are used to manage complex autoimmune disorders and prevent transplant rejection (Goodman & Gilman's The Pharmacological Basis of Therapeutics). While targeting multiple pathways can provide high efficacy in multi-factorial diseases, it often carries significant safety risks, including generalized immunosuppression and increased susceptibility to opportunistic infections (National Institutes of Health, 2023). In modern drug development, this term is frequently used to describe the holistic impact of therapies that aim to reprogram the entire immune microenvironment, particularly in oncology and chronic inflammatory conditions.

Other names

Broad immunomodulationSystemic immune pathwaysImmune microenvironment modulationPleiotropic immune targeting

Simultaneous modulation of diverse immune cell subsets and intracellular signaling networks to suppress or enhance the overall immune response.